Who are 3-V Biosciences's investors?

3-V Biosciences's investors include Kleiner Perkins, Westlake Village BioPartners.

How much funding has 3-V Biosciences raised?

3-V Biosciences has disclosed $123.9M raised across 4 rounds.

Where is 3-V Biosciences headquartered?

3-V Biosciences is headquartered in Menlo Park, US.

3-V Biosciences

NASDAQ: SGMT

Menlo Park, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

Rekha HemrajaniExecutive

Merdad ParseyExecutive

Board

David MottBoard director

Beth Seidenberg in 𝕏Board directorFounding Managing Director at Westlake Village BioPartners

James YoungBoard director

Robert GarlandBoard director

Richard RodgersBoard director

Gordon RingoldBoard director

Investors · 2

Kleiner PerkinsreportedMenlo Park · $500K – $15Mvia Beth Seidenberg · board

Westlake Village BioPartnersreportedLos Angeles · $100K – $5Mvia Beth Seidenberg · board

Reported raises · per SEC filings

Form D private placements

$123.9M disclosed across 4 rounds · 2014–2020

▶$69MraisedJan 2021 · 13 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

George KembleExecutive Officer, Director
Dennis HomExecutive Officer
Merdad ParseyDirector
Beth SeidenbergDirector
Gordon RingoldDirector
Jason FullerDirector
James YoungDirector
Richard RodgersDirector
Jinzi Jason WuDirector

Offering amount: $80M
Amount sold: $69M
First sale: Dec 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$35.2MraisedFeb 2019 · 19 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

George KembleExecutive Officer, Director
Xufang DuanDirector
Jason FullerDirector
Merdad ParseyDirector
David MottDirector
Beth SeidenbergDirector
Richard RodgersDirector
Gordon RingoldDirector
Dennis HomExecutive Officer
Jinzi Jason WuDirector
James YoungDirector

Offering amount: $42.2M
Amount sold: $35.2M
First sale: Feb 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.4MraisedJul 2016 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

James YoungDirector
David MottDirector
Beth SeidenbergDirector
Gordon RingoldDirector
Jason FullerDirector
Merdad ParseyDirector
Richard RodgersDirector
George KembleExecutive Officer, Director

Offering amount: $12M
Amount sold: $5.4M
First sale: Jun 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$14.3MraisedMar 2015 · 12 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David MottDirector
Rekha HemrajaniExecutive Officer
Beth SeidenbergDirector
Richard RodgersDirector
Gordon RingoldDirector
Merdad ParseyExecutive Officer, Director
James YoungDirector
Robert GarlandDirector

Offering amount: $35M
Amount sold: $14.3M
First sale: Oct 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are 3-V Biosciences's investors?: 3-V Biosciences's investors include Kleiner Perkins, Westlake Village BioPartners.
How much funding has 3-V Biosciences raised?: 3-V Biosciences has disclosed $123.9M raised across 4 rounds.
Where is 3-V Biosciences headquartered?: 3-V Biosciences is headquartered in Menlo Park, US.